Labwire, Inc.

As of March 31, 2009, Labwire, Inc. carries a market capitalization of 8.56M, placing it among publicly traded companies globally. Its enterprise value stands at 9.52M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of March 31, 2009, Labwire, Inc. has 142.70M shares outstanding.

These figures are as of March 31, 2009. The price-to-sales ratio is 1.90, and the price-to-book ratio stands at -189.47.

As of March 31, 2009, Labwire, Inc. trades at an EV/EBITDA multiple of 131.95 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 2.13 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 1,941.63 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 9.52M versus a market cap of 8.56M, with the gap driven by net debt and cash on the balance sheet.

As of March 31, 2009, Labwire, Inc. maintains a current ratio of 0.67, meaning it holds 0.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -2,265.64, indicating conservative leverage, while an interest coverage ratio of 0.58 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended March 31, 2009. Return on assets (ROA) is negative at -9.88, reflecting losses generated across the asset base. The company generates approximately 638,157.86 in revenue per employee across its workforce of 7.00, a quick read on workforce productivity versus industry peers.

Over the twelve months ended March 31, 2009, Labwire, Inc. recorded 46,625.00 in income tax expense. The company reported a pretax loss of -119,580.00 and -166,205.00 in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on September 24, 2026, Labwire, Inc.'s stock has gained approximately 300.00% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.01.

Over the twelve months ended March 31, 2009, Labwire, Inc. generated 4.47M in revenue and converted that into -166,205.00 in net income, yielding earnings per share of 0.00. EBITDA reached 72,163.00, while operating income came in at 4,904.00.

As of March 31, 2009, Labwire, Inc. holds 64,007.00 in cash and equivalents against 1.02M in total debt, resulting in a net debt position of 959,834.00. Total book value stands at -45,190.00, with working capital of -512,059.00 providing operational flexibility.

Labwire, Inc. produced 77,496.00 in operating cash flow over the twelve months ended March 31, 2009. After subtracting -159,870.00 in capital expenditures, free cash flow totaled -82,374.00 - equivalent to 0.00 per share.

Over the twelve months ended March 31, 2009, Labwire, Inc. posted a gross margin of 43.76, reflecting its pricing power and cost economics. The operating margin of 0.11 and net profit margin of -3.72 provide insight into operational efficiency.

These figures cover the twelve months ended March 31, 2009. Free cash flow yield is negative at -0.97: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield reaches 0.07, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Labwire, Inc. shareholders.

As of March 31, 2009, Labwire, Inc. has an Altman Z-Score of 4.81, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.